Quick Links
Quick Links
The investment objective of the Fund is to track the performance of European large and mid-sized companies in the Health Care sector.
The MSCI Europe Health Care 35/20 Capped Index is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of constituents classified as Health Care (according to the Global Industry Classification Standard) in the MSCI Europe index.
ISIN | IE00BKWQ0H23 |
iNAV Ticker
*These ticker codes are representative of the primary listing exchange. |
INSTW |
Inception Date | 05 Dec 2014 |
Countries of Registration | Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom |
Base Fund Currency | EUR |
Income Treatment | Accumulation |
Settlement Cycle | Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2 |
Trading Cycle | DD |
TER | 0,18% |
Benchmark | MSCI Europe Health Care 35/20 Capped Index |
Minimum Investment | 1 Share |
Trading Currency | CHF, EUR, GBP, MXN |
UCITS Compliant | Yes |
Domicile | Ireland |
Investment Manager | State Street Global Advisors Europe Limited |
Sub-Investment Manager(s) | State Street Global Advisors Limited |
Fund Umbrella | SSGA SPDR ETFs Europe II plc |
Replication Method | Replicated |
Distribution Frequency | - |
PEA Eligible | No |
ISA Eligible | Yes |
SIPP Eligible | Yes |
UK Reporting Status | Yes |
Securities Lending | Yes |
Exchange | Trading Currency | Listing Date | Exchange Ticker | SEDOL Code | Bloomberg Code | Reuters Code |
---|---|---|---|---|---|---|
Euronext Paris (Primary) | EUR | 08 Dec 2014 | STW | BM67JF6 | STW FP | STW.PA |
SIX Swiss Exchange | CHF | 09 Dec 2014 | STWX | BM67JH8 | STWX SE | STWX.S |
Deutsche Börse | EUR | 09 Dec 2014 | SPYH | BKX4075 | SPYH GY | SPYH.DE |
London Stock Exchange | EUR | 09 Dec 2014 | HLTH | BSBNC41 | HLTH LN | HLTH.L |
Borsa Italiana | EUR | 10 Dec 2014 | STWX | BM67JG7 | STWX IM | STWX.MI |
Bolsa Mexicana de Valores | MXN | 12 Feb 2019 | HLTHN | BJCWGN1 | HLTHN MM | HLTHN.MX |
London Stock Exchange | GBP | 04 Apr 2022 | HEAE | BKWQ0H2 | HEAE LN | HEAE.L |
Estimated NAV per Unit at 4PM, Hong Kong as of | |
Estimated NAV per Unit as of (Updated every 15 seconds) |
INAV TICKER | CURRENCY | INAV |
---|
The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.
Average Market Cap (M) | €153 005,31 M |
Number of Holdings | 43 |
Average Price/Book | 3,90 |
Price/Earnings Ratio FY1 | 16,97 |
Index Dividend Yield
This measures the weighted average of gross dividend Yield of stocks, in the index. |
2,19% |
Bid Price | €205,10 |
Offer Price | €237,20 |
Closing Price | €218,80 |
Bid/Offer Spread | €32,10 |
Day High | €218,80 |
Day Low | €214,70 |
52 Week High | €248,30 |
52 Week Low | €192,34 |
NAV EUR (Official NAV) | €218,75 |
NAV CHF | CHF 203,52 |
NAV GBP | £181,81 |
NAV MXN | MXN $4 672,25 |
Assets Under Management | €659,86 M |
Shares in Issue | 3 016 500 |
Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.
as of 31 Oct 2024
As Of | 1 Month | 3 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception 30 Sep 2001 |
|
---|---|---|---|---|---|---|---|---|---|
Fund Net | 31 Oct 2024 | -3,80% | -6,79% | 10,28% | 16,15% | 5,79% | 8,20% | 7,02% | 6,07% |
Difference | 31 Oct 2024 | -0,01% | -0,02% | 0,01% | -0,03% | -0,04% | -0,08% | -0,11% | -0,25% |
Fund Gross | 31 Oct 2024 | -3,78% | -6,75% | 10,44% | 16,36% | 5,98% | 8,44% | 7,29% | 6,46% |
Difference | 31 Oct 2024 | 0,01% | 0,02% | 0,17% | 0,18% | 0,15% | 0,16% | 0,16% | 0,13% |
Index
MSCI Europe Health Care 35/20 Capped Index
Index Change: “Index” reflects linked performance returns of both the MSCI Europe Health Care 35/20 Capped Index and the MSCI Europe Health Care Index. The index returns are reflective of the MSCI Europe Health Care Index from fund inception until November 30, 2020 and of MSCI Europe Health Care 35/20 Capped Index effective November 30, 2020 to present. |
31 Oct 2024 | -3,79% | -6,77% | 10,27% | 16,18% | 5,83% | 8,28% | 7,13% | 6,32% |
as of 31 Oct 2024
As Of | 1 Month | 3 Month | YTD | 1 Year | 3 Year | 5 Year | 10 Year | Since Inception 30 Sep 2001 |
|
---|---|---|---|---|---|---|---|---|---|
Fund Net | 31 Oct 2024 | -3,80% | -6,79% | 10,28% | 16,15% | 18,40% | 48,34% | 97,06% | 290,20% |
Difference | 31 Oct 2024 | -0,01% | -0,02% | 0,01% | -0,03% | -0,14% | -0,55% | -2,10% | -21,38% |
Fund Gross | 31 Oct 2024 | -3,78% | -6,75% | 10,44% | 16,36% | 19,05% | 49,96% | 102,22% | 323,78% |
Difference | 31 Oct 2024 | 0,01% | 0,02% | 0,17% | 0,18% | 0,50% | 1,08% | 3,06% | 12,21% |
Index
MSCI Europe Health Care 35/20 Capped Index
Index Change: “Index” reflects linked performance returns of both the MSCI Europe Health Care 35/20 Capped Index and the MSCI Europe Health Care Index. The index returns are reflective of the MSCI Europe Health Care Index from fund inception until November 30, 2020 and of MSCI Europe Health Care 35/20 Capped Index effective November 30, 2020 to present. |
31 Oct 2024 | -3,79% | -6,77% | 10,27% | 16,18% | 18,54% | 48,88% | 99,16% | 311,57% |
as of 31 Oct 2024
2024 (YTD) | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Fund Net | 10,28% | 8,40% | -4,46% | 25,32% | -2,05% | 31,62% | -0,70% | 2,75% | -9,49% | 14,77% | 19,11% |
Difference | 0,01% | 0,00% | -0,08% | -0,11% | -0,15% | -0,15% | -0,12% | -0,12% | -0,11% | -0,26% | -0,17% |
Fund Gross | 10,44% | 8,59% | -4,29% | 25,61% | -1,76% | 32,02% | -0,40% | 3,05% | -9,22% | 15,12% | 19,47% |
Difference | 0,17% | 0,19% | 0,09% | 0,18% | 0,15% | 0,24% | 0,18% | 0,19% | 0,16% | 0,09% | 0,19% |
Index
MSCI Europe Health Care 35/20 Capped Index
Index Change: “Index” reflects linked performance returns of both the MSCI Europe Health Care 35/20 Capped Index and the MSCI Europe Health Care Index. The index returns are reflective of the MSCI Europe Health Care Index from fund inception until November 30, 2020 and of MSCI Europe Health Care 35/20 Capped Index effective November 30, 2020 to present. |
10,27% | 8,40% | -4,38% | 25,43% | -1,90% | 31,77% | -0,58% | 2,86% | -9,38% | 15,03% | 19,28% |
Performance Gross and Net of All Fees.
Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.
Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.
Index Change: “Index” reflects linked performance returns of both the MSCI Europe Health Care 35/20 Capped Index and the MSCI Europe Health Care Index. The index returns are reflective of the MSCI Europe Health Care Index from fund inception until November 30, 2020 and of MSCI Europe Health Care 35/20 Capped Index effective November 30, 2020 to present.
Standard Deviation | 12,53% |
Tracking Error | 0,11% |
This calculation is based on the past 3 years performance information.
Security Name | Weight |
---|---|
Novo Nordisk A/S Class B | 20,40% |
Novartis AG | 12,70% |
Roche Holding Ltd Dividend Right Cert. | 12,41% |
AstraZeneca PLC | 12,26% |
Sanofi | 6,78% |
EssilorLuxottica SA | 4,52% |
GSK plc | 4,27% |
Alcon AG | 2,66% |
Lonza Group AG | 2,65% |
argenx SE | 2,21% |
Regulatory Reports
Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.
Capital Risk: Investing involves risk including the risk of loss of capital.
Past performance is not a reliable indicator of future performance.
First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.
The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSGA and any related financial products.
Index Change: “Index” reflects linked performance returns of both the MSCI Europe Health Care 35/20 Capped Index and the MSCI Europe Health Care Index. The index returns are reflective of the MSCI Europe Health Care Index from fund inception until November 30, 2020 and of MSCI Europe Health Care 35/20 Capped Index effective November 30, 2020 to present.
The recipient is only permitted to view or receive the Index Data in the form in which it is in presented. The recipient understands, acknowledges and agrees that use of the Index Data is at its sole risk. The recipient understands, acknowledges and agrees that the Index Data is provided "as is" and that neither Morningstar UK Limited (Morningstar) nor its content providers warrant the accuracy, completeness, non-infringement, originality, timeliness or any other characteristic of the Index Data. The recipient further understands, acknowledges and agrees that the Index Data is provided to you as an investor in financial products solely pursuant to regulatory requirements and for informational purposes only. The Index Data may not be used by you for commercial purposes and may not be used for trading or other purposes in lieu of a subscription to such Index Data with Morningstar.